|Primary analysis complete
|Study Start Date:
|Study Made Public:
A Phase II clinical trial to evaluate the immunogenicity and safety of a combined regimen using ALVAC vCP1452 and AIDSVAX B/B
HVTN 203 is a Phase II clinical trial to evaluate the safety and immunogenicity of ALVAC vCP1452 and AIDSVAX B/B.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.